Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils:a randomized, placebo-controlled clinical trial
| Data(s) |
01/07/2012
|
|---|---|
| Resumo |
Increased numbers of neutrophils are reported in the airways of patients with severe asthma. It is not clear if they contribute to the lack of control and severity. There are currently no strategies to investigate this by decreasing neutrophil numbers in the airways. |
| Identificador | |
| Idioma(s) |
eng |
| Direitos |
info:eu-repo/semantics/restrictedAccess |
| Fonte |
Nair , P , Gaga , M , Zervas , E , Alagha , K , Hargreave , F E , O'Byrne , P M , Stryszak , P , Gann , L , Sadeh , J , Chanez , P , Study Investigators & Heaney , L 2012 , ' Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils : a randomized, placebo-controlled clinical trial ' Clinical & Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology , vol 42 , no. 7 , pp. 1097-103 . DOI: 10.1111/j.1365-2222.2012.04014.x |
| Palavras-Chave | #/dk/atira/pure/subjectarea/asjc/2400/2403 #Immunology #/dk/atira/pure/subjectarea/asjc/2700/2723 #Immunology and Allergy |
| Tipo |
article |
